Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
47.6M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
37.8M
-
Shares change
-
+578K
-
Total reported value, excl. options
-
$119M
-
Value change
-
-$275K
-
Number of buys
-
16
-
Number of sells
-
-36
-
Price
-
$3.15
Significant Holders of ESSA Pharma Inc. - Common Shares (EPIX) as of Q2 2022
72 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares as of Q2 2022.
ESSA Pharma Inc. - Common Shares (EPIX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.8M shares
of 47.6M outstanding shares and own 79.35% of the company stock.
Largest 10 shareholders include Bellevue Group AG (5.01M shares), Soleus Capital Management, L.P. (4.17M shares), BVF INC/IL (3.7M shares), MORGAN STANLEY (3.67M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.37M shares), JANUS HENDERSON GROUP PLC (2.91M shares), RTW INVESTMENTS, LP (2.64M shares), Avidity Partners Management LP (2.46M shares), Blackstone Inc. (2M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.04M shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.